The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL-Reference-Cited by-同舟云学术

The predictive strength of next-generation sequencing MRD detection for relapse compared with current methods in childhood ALL

Published:2015-08-20 Issue:8 Volume:126 Page:1045-1047
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Kotrova Michaela¹,Muzikova Katerina¹,Mejstrikova Ester¹,Novakova Michaela¹,Bakardjieva-Mihaylova Violeta¹,Fiser Karel¹,Stuchly Jan¹,Giraud Mathieu²,Salson Mikaël²,Pott Christiane³,Brüggemann Monika³,Füllgrabe Marc³,Stary Jan⁴,Trka Jan¹,Fronkova Eva¹

Affiliation:

1. Childhood Leukaemia Investigation Prague (CLIP), Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

2. CRIStAL (Centre de Recherche en Informatique, Signal et Automatique de Lille), Unité Mixte de Recherche (UMR CNRS 9189), Université de Lille and Inria Lille, Lille, France

3. Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany

4. Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/126/8/1045/1391490/1045.pdf

Reference10 articles.

1. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies.;Van Dongen;Blood,2015

2. Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.;Logan;Leukemia,2013

3. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia.;Faham;Blood,2012